NMS-P715 |
Inhibitor of TTK
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| TTK |
|
|
Inhibitor
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
Selective against Aur-A, CDK2/A, PLK1
Potency Cellular
In Vitro
TTK
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1016/j.bmcl.2011.05.122
In Vivo Validations
Mouse
Dose: 10 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
7.65 ± 0.83 h
Systemic clearance:
10.0 ± 0.24 mL/min/kg
Area Under the Curve::
22.4 ± 0.81 μM h
Volume of Distribution at Steady-State:
5.45 ± 0.55 L/Kg
DOI Reference: 10.1016/j.bmcl.2011.05.122
Dose: 10 mg/Kg
Route of delivery:
Oral
Plasma half life:
8.01 ± 1.32 h
Cmax:
0.600 ± 0.150 uM
Area Under the Curve::
8.66 ± 2.09 μM h
Bioavailability:
37.9%
DOI Reference: 10.1016/j.bmcl.2011.05.122
Chemical Information
| Molecular Formula | C35H39F3N8O3 |
| SMILEs | CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC(F)(F)F)nc1-2 |
| InChI | InChI=1S/C35H39F3N8O3/c1-5-20-8-7-9-21(6-2)28(20)42-33(48)30-25-12-10-23-19-39-34(43-29(23)31(25)46(4)44-30)41-26-13-11-22(18-27(26)49-35(36,37)38)32(47)40-24-14-16-45(3)17-15-24/h7-9,11,13,18-19,24H,5-6,10,12,14-17H2,1-4H3,(H,40,47)(H,42,48)(H,39,41,43) |
| Molecular weight | 676.31 Da |
| AlogP | 5.819 |
| HBond acceptors | 11 |
| HBond donors | 3 |
| Atoms | 88 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.